Directory
>
Gary Herman
Gary Herman
Senior Vice President, Early Clinical Development & Experimental Sciences | Regeneron
New Jersey, United States
Gary Herman
Summary
Gary Herman is a distinguished leader in early clinical development and experimental sciences, currently serving as Senior Vice President at Regeneron Pharmaceuticals. With a robust background in medicine and biochemistry, he has a proven track record of driving innovation in drug development across various therapeutic areas. Gary is particularly noted for co-architecting the Januvia development program, which has become Merck's top-selling drug. His extensive experience spans leadership roles at Merck and contributions to the NIH Biomarkers Consortium, showcasing his commitment to advancing medical science. Gary's collaborative approach and strategic vision have enabled him to build high-performing teams and enhance operational efficiencies. He holds an M.D. from Harvard Medical School and a Bachelor's degree from UC San Diego, underscoring his solid educational foundation in the life sciences. Passionate about personalized medicine and addressing unmet medical needs, he continues to inspire the next generation of scientists and leaders in the pharmaceutical industry.
Gary Herman
Work Experience
Senior Vice President, Early Clinical Development & Experimental Sciences at
Regeneron
January 2020 - Present
Vice President, Early Clinical Development at
Regeneron Pharmaceuticals
September 2015 - January 2020
Vice President And Head, Early Stage Development at
Merck
November 2009 - May 2015
Gary Herman
Education
Harvard Medical School, Doctor Of Medicine (M.D.)
University of California San Diego, Bachelor's Degree
University of Sussex, Education Abroad Program
Frequently Asked Questions about Gary Herman
What is Gary Herman email address?
Gary Herman's primary email address is ***********@regeneron.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Gary Herman work for?
Gary Herman is a Senior Vice President, Early Clinical Development & Experimental Sciences at Regeneron, a company specializing in Pharmaceutical preparations.
Where Gary Herman graduated from?
Gary Herman holds a degree in Medicine from Harvard Medical School.
How can I directly contact Gary Herman?
To contact Gary Herman directly, you can use the email address ***********@regeneron.com. Complete contact information is available upon registration with Muraena.
Who is Gary Herman?
Gary Herman is a distinguished leader in early clinical development and experimental sciences, currently serving as Senior Vice President at Regeneron Pharmaceuticals. With a robust background in medicine and biochemistry, he has a proven track record of driving innovation in drug development across various therapeutic areas. Gary is particularly noted for co-architecting the Januvia development program, which has become Merck's top-selling drug. His extensive experience spans leadership roles at Merck and contributions to the NIH Biomarkers Consortium, showcasing his commitment to advancing medical science. Gary's collaborative approach and strategic vision have enabled him to build high-performing teams and enhance operational efficiencies. He holds an M.D. from Harvard Medical School and a Bachelor's degree from UC San Diego, underscoring his solid educational foundation in the life sciences. Passionate about personalized medicine and addressing unmet medical needs, he continues to inspire the next generation of scientists and leaders in the pharmaceutical industry.
Gary`s contact details
***********@regeneron.com
Colleagues
Executive Director, Commercial Finance & Business Planning
Executive Director
Senior Vice President - Global Supply Chain Management
Vice President Regeneron Genetic Medicines
Executive Director Process Sciences
Vice President, New Products Commercialization (Commercial Development)
Executive Director, Customer Insights & Analytics
Executive Director, Analytical Sciences
Executive Director, Global Patient Safety
Executive Director, Global HR Operations & Solutions